Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on March 28th, 2017% A patent dispute among top research universities took another turn, as the European Patent Office announced its intention to grant a patent to University of California for its genome editing techniques. . . . → Read More: Univ. of California to Gain European Crispr-Cas9 Patent
By Alan, on February 21st, 2017% A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure. . . . → Read More: Patent Issued for Peptides in Diabetes Gene Therapy
By Alan, on February 16th, 2017% The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley. . . . → Read More: Patent Office Decides for Broad and Editas in Crispr Case
By Alan, on January 27th, 2017% A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research. . . . → Read More: Simpler Lab Cell Production Techniques Devised
By Alan, on December 13th, 2016% An experimental treatment for pertussis, also known as whooping cough, using engineered humanized antibodies received a patent in the U.S. . . . → Read More: Patent Awarded for Whooping Cough Antibodies
By Alan, on November 7th, 2016% A synthetic engineered antibody developed by MabVax Therapeutics that binds to solid tumor cells for cancer diagnostics and treatment received a U.S. patent. . . . → Read More: Patent Awarded for Cancer-Fighting Antibody
By Alan, on October 5th, 2016% A veterinary medical team at Kansas State University developed a vaccine that protects livestock against dangerous liver and skin infections without antibiotics. . . . → Read More: Vaccine Stops Livestock Infections Without Antibiotics
By Alan, on September 23rd, 2016% Monsanto Company is licensing genomic editing technology for agricultural applications from a joint research center at Harvard University and MIT. . . . → Read More: Monsanto Licensing MIT/Harvard Genome Editing
By Alan, on September 13th, 2016% A technology for fitting and programming a hearing aid online received a U.S. patent earlier this month, awarded to iHear Medical Inc. . . . → Read More: Patent Issued for Online Hearing Aid Calibration
By Alan, on August 30th, 2016% A company developing small-molecule treatments for biological targets considered difficult to address is receiving a patent for its core drug identification technology. . . . → Read More: Small Molecule Drug Discovery Patent Issued
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|